Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced that Siddharth Mittal has assumed the role of Managing Director and Chief Executive Officer of the Company, effective 1 July 2026.
Siddharth succeeds Peter Bains, who completed his tenure as Managing Director & CEO on 30 June 2026.
Commenting on Siddharth's appointment, Kiran Mazumdar-Shaw, Executive Chairperson, Syngene International, said: "I am delighted to welcome Siddharth as the Managing Director and CEO of Syngene. Having worked closely with Siddharth for many years, I have seen first hand his ability to lead businesses through period of change, build strong teams and deliver transformation and sustainable growth.
Having built a strong reputation for scientific excellence, quality and customer trust, Syngene is now at an inflection point in its journey. As the industry evolves and customer expectations continue to rise, I am confident Siddharth's leadership, commercial acumen and execution focus will help Syngene unlock its full potential and create long-term value for our customers, employees and shareholders."
Commenting on taking on the role, Siddharth Mittal said: "I am honoured to take on the role of Managing Director and CEO of Syngene. Over the years, the company has built exceptional scientific capabilities, a talented team, and gained the trust of customers across the world. These enduring strengths give us a solid platform to drive the next phase of long-term growth. My immediate priority is to sharpen our commercial edge, strengthen delivery excellence and bring greater focus and discipline to execution across the business. By combining our scientific strengths and talented workforce with an unwavering focus on customer fulfilment and cost competitiveness, I am confident that we can restore growth momentum and reinforce Syngene’s standing as a global leader in CRDMO services, while creating long-term value for all our stakeholders.”